/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
DISSEMINATION IN THE UNITED
VANCOUVER, BC, Jan. 21, 2021
/CNW/ - Numinus Wellness Inc. ("Numinus" or the
"Company") (TSXV: NUMI), a company creating an ecosystem of
health solutions centered around developing and supporting the
safe, evidence-based, accessible use of psychedelic-assisted
psychotherapies, is pleased to announce that the TSX Venture
Exchange ("TSXV") has accepted for listing the 12,683,925
warrants (the "Warrants") issued pursuant to the Company's
previously announced prospectus offering that closed on
December 29, 2020.
The Warrants will be listed for trading on the TSXV under the
symbol "NUMI.WS" effective at market open on Monday, January 25, 2021.
Each Warrant entitles the holder thereof to acquire one common
share of the Company at an exercise price of $0.90 until December 29,
2022. The Warrants were issued pursuant to, and are governed
by, the terms of a warrant indenture dated December 29, 2020 (the "Warrant
Indenture") between the Company and Computershare Trust Company
of Canada. A copy of the Warrant
Indenture is available under the Company's SEDAR profile at
Numinus Wellness Inc. (TSXV: NUMI) is a mental health and
wellness company creating an ecosystem of solutions centred around
safe, evidence-based, accessible psychedelic-assisted psychotherapy
to help people heal and be well.
Numinus Health is dedicated to delivering innovative treatments
to address physical, mental, and emotional health, through clinics
and virtual services.
Numinus R&D is conducting implementation science and
leveraging partnerships to beta-test and refine optimal models of
psychedelic-assisted psychotherapy delivery, setting the stage for
approved routine use in mental health and wellness care.
Numinus Bioscience is focused on developing testing methods and
effective formulas for the evolving psychedelics space. Health
Canada licences, scientific
expertise, and new technologies facilitate ongoing innovation, and
high-throughput contract services generate established revenue.
Learn more at numinus.ca, and follow us
on Facebook, Twitter, and Instagram.
This news release contains "forward-looking information"
within the meaning of applicable securities laws, including but not
limited to statements relating to the use of proceeds from the
Offering. Although the Company believes, in light of the experience
of its officers and directors, current conditions and expected
future developments and other factors that have been considered
appropriate, that the expectations reflected in this
forward-looking information are reasonable, undue reliance should
not be placed on them because the Company can give no assurance
that they will prove to be correct. Actual results and developments
may differ materially from those contemplated by these statements.
The statements in this press release are made as of the date of
this release and the Company assumes no responsibility to update
them or revise them to reflect new events or circumstances other
than as required by applicable securities laws. The Company
undertakes no obligation to comment on analyses, expectations or
statements made by third-parties in respect of the Company, its
subsidiaries, their securities, or their respective financial or
operating results (as applicable).
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
ON BEHALF OF THE BOARD OF NUMINUS WELLNESS INC.
President, Chief Executive Officer and Chair
SOURCE Numinus Wellness Inc.